REOPRO Solution for injection or infusion (2016)
Active ingredients: Abciximab
Product Name and Form
ReoPro 2 mg/mL solution for injection or infusion.
Solution for injection or infusion.
ReoPro is a colourless and clear liquid.
Qualitative and Quantitative Composition
ReoPro 2 mg/mL contains 10 mg abciximab in 5 mL water for injection.
Abciximab is the Fab fragment of a chimeric IgG1 monoclonal antibody manufactured from a recombinant cell line cultured by continuous perfusion.
For the full list of excipients, see section 6.1.
Abciximab is the Fab fragment of the chimeric monoclonal antibody 7E3. It is directed against the glycoprotein (GP) IIb/IIIa (αIIbβ3) receptor located on the surface of human platelets. Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.
Water for injection
Disodium phosphate dihydrate
Sodium dihydrogen phosphate monohydrate
Pack sizes and Marketing
ReoPro is supplied as a 5 mL solution in a type I borosilicate glass vial with a Teflon-coated rubber stopper and an aluminium crimp protected by a plastic cap in a pack size of one.
Janssen Biologics B.V., Einsteinweg 101, 2333 CB Leiden, The Netherlands
Date of first authorisation: 23 March 1995
Date of last renewal of the authorisation: 22 March 2010